RxDoctor Payments Data

Vishal Verma, MD

Ophthalmology · Huntington, WVNPI 1316131865

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $153,367 of the $159,241 with a category attached, or 96.3%. AbbVie accounts for 83.3% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2022 at $132,900 and has fallen 94.7% since, to $7,083 in 2025. Among ophthalmology clinicians in WV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$159,241in general payments, 2019–2025

Across 113 payments — averaging $1409.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$133K
  • Alcon$26K
  • Johnson & Johnson Surgical Vision, Inc.$316
  • Microsurgical Technology, Inc.$103
  • Bausch & Lomb Americas Inc.$60
  • Rxsight Inc$44

What the payments were for

  • Speaking & faculty fees$153,36796%
  • Travel & lodging$2,3051%
  • Food & beverage$3,5692%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$159,241 in reported general payments places this provider in the 95th percentile of 85 ophthalmology providers in West Virginia.

See all ophthalmology providers in West Virginia

Medicare billing

Part B allowed, 2024
$558,803
Medicare patients
630
Services billed
3,066

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate958$48,665
Bromfenac Sodium198$22,802
Tobramycin909$5,428
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat88$1,400
Brimonidine Tartrate28$935
Timolol Maleate86$759
Gatifloxacin16$753
Diclofenac Sodium42$498
Latanoprost68$369
Tramadol Hcl15$19
Diazepam14$18

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Huntington

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →